-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Ensysce Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
- Ensysce Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $17K, a 3.12% increase year-over-year.
- Ensysce Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$1.62M, a 239% decline year-over-year.
- Ensysce Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $91.9K, a 538% increase from 2022.
- Ensysce Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $14.4K.
- Ensysce Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was -$9.28M, a 739% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)